Cystic Fibrosis: Modern Diagnostic and Therapeutic Advances from Molecular Pathogenesis to Multidisciplinary Management
Genes · 27.06.2026 · 17 (7) · 743
DOI: 10.3390/genes17070743 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 27.06.2026. Verfasst von Liqin Ke und 3 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, Han…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cystic fibrosis (CF) is an autosomal recessive disorder caused by pathogenic variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. It is increasingly understood through a genomics-informed framework linking variant architecture to phenotype, diagnosis, and therapeutic eligibility. This review summarizes current evidence on CFTR structure, variant interpretation, genotype-phenotype heterogeneity, diagnostic workflows, and modern management. We highlight how full-gene sequencing, curated disease-liability databases, functional testing, and organoid-informed theratyping refine diagnosis and treatment selection; how disrupted chloride and bicarbonate transport drives muco-obstructive airway disease and multisystem complications; and why modulator therapy must still be integrated with respiratory, nutritional, endocrine, hepatobiliary, reproductive, and psychosocial care. We also outline unresolved challenges in rare variants, residual organ damage, ancestry-related diagnostic gaps, and mutation-agnostic therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, Hangzhou 310052, China.
Zitieren
APA
Ke, L., Guan, L., Bao, Y., & Tang, C. (2026). Cystic Fibrosis: Modern Diagnostic and Therapeutic Advances from Molecular Pathogenesis to Multidisciplinary Management. Genes, 17(7), 743. https://doi.org/10.3390/genes17070743
Vancouver
Ke L, Guan L, Bao Y, Tang C. Cystic Fibrosis: Modern Diagnostic and Therapeutic Advances from Molecular Pathogenesis to Multidisciplinary Management. Genes. 2026;17(7):743. doi:10.3390/genes17070743
BibTeX
@article{Ke2026,
author = {Ke, Liqin and Guan, Lijun and Bao, Yiyao and Tang, Chao},
title = {Cystic Fibrosis: Modern Diagnostic and Therapeutic Advances from Molecular Pathogenesis to Multidisciplinary Management},
journal = {Genes},
year = {2026},
volume = {17},
number = {7},
pages = {743},
doi = {10.3390/genes17070743}
}
EUVIMED